Max T. Baker, PhD, Founder and Associate Professor, Department of Anesthesia, University of Iowa Carver College of Medicine. Clipse Therapeutics, LLC, is a University of Iowa spinoff company founded to develop safe, effective and reliable drug delivery methods for serious medical conditions

 

Our first product is BuccalStay, a unique buccal drug delivery device that allows for quick application and rapid drug uptake in any environment.  BuccalStay provides accelerated and effective treatments for a range of life-threatening or severe conditions, such as seizure episodes, opioid overdose, pain, others. 

 

BuccalStay advantages:

  • Noninvasive and rapid drug uptake via buccal membranes
  • Consistent absorption compared to current treatments
  • Easy to administer; circumvents swallowing or choking hazards
  • Flexible drug-release options – immediate or extended, low or high drug capacity
  • Minimized likelihood of overdosing

 

BuccalStay can deliver a variety of proprietary, generics, over the counter drugs and nutraceuticals

Max T. Baker, PhD, Founder and Associate Professor, Department of Anesthesia, University of Iowa Carver College of Medicine. Clipse Therapeutics, LLC, is a University of Iowa spinoff company founded to develop safe, effective and reliable drug delivery methods for serious medical conditions

 

Our first product is BuccalStay, a unique buccal drug delivery device that allows for quick application and rapid drug uptake in any environment.  BuccalStay provides accelerated and effective treatments for a range of life-threatening or severe conditions, such as seizure episodes, opioid overdose, pain, others. 

 

BuccalStay advantages:

  • Noninvasive and rapid drug uptake via buccal membranes
  • Consistent absorption compared to current treatments
  • Easy to administer; circumvents swallowing or choking hazards
  • Flexible drug-release options – immediate or extended, low or high drug capacity
  • Minimized likelihood of overdosing

 

BuccalStay can deliver a variety of proprietary, generics, over the counter drugs and nutraceuticals

Venture Information
Stage: 
Seed
Industry: 
Medical Devices
Type of Product: 
drug delivery device
Market: 
Delivery of proprietary, generics, over the counter drugs and nutraceuticals
Funding Round: 
Seed
Company Information
Founded: 
May 27, 2015
Founders: 
Max T. Baker, PhD